Clinical Trial Update: Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM [NA]

View source ↗

Summary

A CHUM-based study is evaluating the NeoRetina artificial intelligence algorithm for screening diabetic retinopathy, including diabetic macular edema, and is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Diabetic Retinopathy, Diabetic Macular Edema | NA | Status: RECRUITING